Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA7 | P43166 | 2/20 | 0.54 |
| ▸ | CA9 | Q16790 | 2/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.54 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.52 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.52 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.47 |
| ▸ | KDM4A | O75164 | 2/20 | 0.46 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29996206 | 0.84 | NR4A1 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL464977 | 0.84 | NR4A1 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31401786 | 0.84 | NR4A1 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3388914 | 0.84 | CA12 (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3238461 | 0.83 | CA1 (0.59) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3389447 | 0.82 | NR4A1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30388521 | 0.82 | NR4A1 (0.53) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11857852 | 0.81 | NR4A1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10012443 | 0.81 | NR4A1 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL27985 | 0.81 | NR4A1 (0.73) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8188316-B2 | Integrated process for the preparation of polybenzimidazole precursors | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-29 | — | — | US | claimed |
| US-20100160679-A1 | INTEGRATED PROCESS FOR THE PREPARATION OF POLYBENZIMIDAZOLE PRECURSORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-24 | — | — | US | claimed |
| EP-1931617-A2 | METHOD OF MAKING AROMATIC DIHYDROXY DIACID DIHALIDES AND PRECIPITATES RESULTING THEREFROM | E.I.Du pont de nemours and company (US) | 2008-06-18 | — | — | EP | claimed |
| WO-2007008888-A2 | METHOD OF MAKING AROMATIC DIHYDROXY DIACID DIHALIDES AND PRECIPITATES RESULTING THEREFROM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-01-18 | — | — | WO | claimed |
| US-8445175-B2 | Composition containing hydroxylated condensation resin for forming resist underlayer film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| US-8445175-B2 | Composition containing hydroxylated condensation resin for forming resist underlayer film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2013-05-21 | — | — | US | disclosed |
| US-8188316-B2 | Integrated process for the preparation of polybenzimidazole precursors | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2012-05-29 | — | — | US | disclosed |
| US-20100160679-A1 | INTEGRATED PROCESS FOR THE PREPARATION OF POLYBENZIMIDAZOLE PRECURSORS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-06-24 | — | — | US | disclosed |
| US-20090317740-A1 | Composition containing hydroxylated condensation resin for forming resist underlayer film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
| US-20090317740-A1 | Composition containing hydroxylated condensation resin for forming resist underlayer film | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-12-24 | — | — | US | disclosed |
| EP-2042927-A1 | COMPOSITION CONTAINING HYDROXYLATED CONDENSATION RESIN FOR FORMING FILM UNDER RESIST | Nissan Chemical Industries, Ltd. (JP) | 2009-04-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160679-A1 | INTEGRATED PROCESS FOR THE PREPARATION OF POLYBENZIMIDAZOLE PRECURSORS | DDC, DDT, PDCD2L | CA12 2175/4885CA1 2537/4885CA2 1415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.